shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg"
JIN-POS-6dc588a4-13,Z4951847503,C17H12ClFN2O,Achiral,314.741,100,200415-FTE / COVID-19,,,0,40,20,1326826-Y40-08,03_A,FC=1C=CC=C2C(NC(=O)CC=3C=CC=C(Cl)C3)=CN=CC12,2-(3-chlorophenyl)-N-(8-fluoroisoquinolin-4-yl)acetamide,H3114386,
ALP-UNI-dbb9503d-1,Z4992038943,C20H17ClN2O2,Racemic or presumed racemic or meso,352.814,92.29,200415-FTE / COVID-19,,,0,40,20,1326826-Y40-08,03_B,COC1(CCN(C1=O)C=2C=NC=C3C=CC=CC23)C=4C=CC=C(Cl)C4,3-(3-chlorophenyl)-1-(isoquinolin-4-yl)-3-methoxypyrrolidin-2-one,H3114310,
EDJ-MED-cf4b0d25-2,Z4949474116,C27H29ClN4O3,Diastereomeric mixture,492.997,91.5,200415-FTE / COVID-19,,,0,40,20,1326826-Y40-08,03_C,ClC=1C=CC=C(C1)C(NC[C@@H]2CC[C@@H](O2)C(=O)N3CCCC3)C(=O)NC=4C=NC=C5C=CC=CC45,"2-(3-chlorophenyl)-N-(isoquinolin-4-yl)-2-({[(2S,5R)-5-(pyrrolidine-1-carbonyl)oxolan-2-yl]methyl}amino)acetamide",H3116614,
MAT-POS-4223bc15-7,Z4973388896,C22H20ClN3O4S,Racemic or presumed racemic or meso,457.929,93.7,200415-FTE / COVID-19,,,0,40,20,1326826-Y40-08,03_D,ClC=1C=CC=2CN(CC(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1)S(=O)(=O)C5COC5,"6-chloro-N-(isoquinolin-4-yl)-2-(oxetane-3-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3116763,
